Please login to the form below

Not currently logged in
Email:
Password:

drug delivery

This page shows the latest drug delivery news and features for those working in and with pharma, biotech and healthcare.

FDA panel rejects Aradigm/Grifols’ inhaled antibiotic

FDA panel rejects Aradigm/Grifols’ inhaled antibiotic

In the briefing document, the FDA reviewer concluded that one of Aradigm’s pivotal studies for the inhaled antibiotic - ORBIT-3 - failed to show a treatment effect for the drug while ... Linhaliq is a once-daily formulation of the widely-used antibiotic

Latest news

More from news
Approximately 3 fully matching, plus 187 partially matching documents found.

Latest Intelligence

  • A new era of smart pharma A new era of smart pharma

    Blending Reportum with AI and Robotic tools affords pharma companies the opportunity to transform their end-to-end drug safety processes today. ... Medical adherence is being improved. Drug delivery technology has improved significantly in recent years.

  • A quest for innovative solutions A quest for innovative solutions

    to more than 300 with the creation of PRISM (Patient Relevant Innovative Solutions Mission) which seeks out the nuggets of therapeutic value and delivery innovation. ... Technology’s attractive calling card is the monitoring and collection of data that

  • Breakthrough innovation Breakthrough innovation

    Many pharmaceutical companies are increasingly looking to innovate through the development of companion diagnostics and drug delivery devices, and/or services such as patient monitoring and adherence support. ... Case study: developing a breakthrough

  • Gene therapy Gene therapy

    raised. As do their profiles, to escape the negative connotations of ‘standard’drug delivery/platform companies. ... Cracking gene therapy delivery is very different from marginally improving the pharmacokinetics profile of an existing drug with a

  • Deal Watch August 2016 Deal Watch August 2016

    For example, Allergan has acquired ForSight Visions, a company that has developed a peri-ocular device that allows extended release of a drug to reduce intra-ocular pressure in glaucoma patients. ... 105. ForSight Visions. Allergan. Company acquisition.

More from intelligence
Approximately 0 fully matching, plus 20 partially matching documents found.

Latest appointments

  • Concept Life Sciences adds to its scientific and commercial team Concept Life Sciences adds to its scientific and commercial team

    Dr Calvert has experience in the delivery of integrated drug discovery and development solutions, supporting organisations ranging from virtual companies to global pharma. ... He joins Concept from Aptuit, where he held various roles including senior

  • Philips promotes Simon McGuire to health systems lead Philips promotes Simon McGuire to health systems lead

    Philips promotes Simon McGuire to health systems lead. He was previously GM at Philips Respironics Respiratory Drug Delivery. ... McGuire was previously Philips' general manager of respiratory drug delivery in sleep and respiratory care, having joined

  • Albumedix appoints Dr Giles Campion as CMO Albumedix appoints Dr Giles Campion as CMO

    Dr Campion will be responsible for the firm's global development efforts, with a particular focus on its albumin-based drug delivery platform. ... He brings over 25 years of drug development experience to the role, most recently as group vice president

  • Catalent appoints two board members Catalent appoints two board members

    Catalent appoints two board members. Jack Stahl and Rolf Classon to advise drug development, delivery and supply company. ... Jack Stahl, former CEO of cosmetics firms Revlon, and Rolf Classon, former chairman at Bayer Healthcare, will use to their

  • MedImmune appoints Dr Anand Subramony MedImmune appoints Dr Anand Subramony

    MedImmune appoints Dr Anand Subramony. He joins from Novartis to take up drug delivery and device development role. ... AstraZeneca's MedImmune unit has appointed Dr Anand Subramony as its new vice president of drug delivery and device development.

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • Patient Centricity: Turning Rhetoric into Reality

    However is this transformation working? A patient-centric model demands huge investment and a company-wide commitment to putting patient wants and needs first during all stages of healthcare delivery, from ... drug discovery through to long-term disease

  • Catalent Pharma Solutions

    Catalent Pharma Solutions. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics